Inotropes are medications that alter the force or energy of heart muscle contractions.
They are primarily used in critical care settings to stabilize patients with life-threatening heart conditions by ensuring vital organs receive adequate blood and oxygen.
Types of Inotropes There are two main categories based on their effect on the heart muscle:
Positive Inotropes: These strengthen the force of the heartbeat, allowing the heart to pump more blood with fewer beats.
They are critical for treating conditions where the heart is too weak to meet the body’s needs, such as: Congestive heart failure Cardiogenic shock Septic shock.
Negative Inotropes: These weaken the force of contractions to reduce the heart’s workload.
They are used for managing: Hypertension Chest pain (angina). Abnormal heart rhythms (arrhythmias)
## Common Inotropic Agents Clinicians often select agents based on their specific [pharmacological profile](https://pmc.ncbi.nlm.nih.gov/articles/PMC11242653/): [7]
Catecholamines | Dobutamine, Dopamine, Epinephrine-Increase contractility via beta-adrenergic receptors.
PDE3 Inhibitors | Milrinone, Amrinone-Increase contractility and cause vasodilation
Calcium Sensitizers | Levosimendan | Enhance heart’s sensitivity to calcium without increasing oxygen demand.
Cardiac Glycosides | Digoxin | Strengthens beats by increasing intracellular calcium; used for chronic management.
Administration: Most positive inotropes are administered via intravenous (IV) infusion in an ICU setting to allow for constant monitoring of vital signs and heart rhythm.
Long-term use of positive inotropes is associated with an increased risk of death and arrhythmias, they are typically used at the lowest effective dose for the shortest time possible.
Weaning: Patients are carefully weaned off these medications as their heart function stabilizes.
Positive inotropes increase contractility
Cardiac glycosides
Digoxin — inhibits Na⁺/K⁺-ATPase, increasing intracellular Ca²⁺; used in heart failure and atrial fibrillation; narrow therapeutic window
Catecholamines Dobutamine — β1 agonist; first-line for acute decompensated heart failure Dopamine — dose-dependent: low dose (renal vasodilation), mid dose (β1), high dose (α1) Norepinephrine — primarily α1 with some β1; used in septic shock Epinephrine — α and β agonist; used in cardiac arrest and anaphylaxis Phosphodiesterase-3 inhibitors Milrinone, Enoximone — inhibit cAMP breakdown → increased Ca²⁺; also cause vasodilation, used when dobutamine is insufficient or contraindicated
Calcium sensitizers
Levosimendan — sensitizes troponin C to Ca²⁺ without increasing O₂ demand; also a PDE inhibitor; used in acute heart failure
Negative inotropes which decrease contractility
Beta-blockers (e.g., metoprolol, carvedilol) Calcium channel blockers (verapamil, diltiazem) Antiarrhythmics (e.g., flecainide)
Used in cardiogenic shock, acute decompensated heart failure, post-cardiac surgery low output states
Most positive inotropes increase myocardial O₂ demand — a key trade-off Many are IV only, used in ICU/monitored settings Chronic use of most positive inotropes (except digoxin) is associated with increased mortality